Does Low Threshold Value Use Improve Proximal Neoplasia Detection by Fecal Immunochemical Test?

Digestive Diseases and Sciences

Volumn 61, Issue 9, 2016, Pages 2685-2693

  Kim, Nam Hee ^a   Yang, Hyo Joon ^a   Park, Soo Kyung ^a   Park, Jung Ho ^a   Park, Dong Il ^a   Sohn, Chong Il ^a   Choi, Kyuyong ^a   Jung, Yoon Suk ^a  

^a School of Medicine   (South Korea)

Author keywords

Advanced colorectal neoplasia; Distal; Fecal immunochemical test; Proximal

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER LOCALIZATION; COLONOSCOPY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FECAL IMMUNOCHEMICAL TEST; FECES ANALYSIS; FEMALE; HUMAN; IMMUNOCHEMISTRY; INVESTIGATIVE PROCEDURES; KOREA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PREDICTIVE VALUE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; UNIVERSITY HOSPITAL; ADENOMA; ASCENDING COLON; CARCINOMA; CECUM; CHEMISTRY; COLORECTAL NEOPLASMS; DESCENDING COLON; EARLY CANCER DIAGNOSIS; FECES; PATHOLOGY; RECTUM; SIGMOID; SOUTH KOREA; TRANSVERSE COLON;

HEMOGLOBIN;

ADENOMA; AGED; CARCINOMA; CECUM; COLON, ASCENDING; COLON, DESCENDING; COLON, SIGMOID; COLON, TRANSVERSE; COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FECES; FEMALE; HEMOGLOBINS; HUMANS; IMMUNOCHEMISTRY; MALE; MIDDLE AGED; RECTUM; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 84964258721     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-016-4169-3     Document Type: Article

References (35)

1. Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893–2917.
2. Inra JA, Syngal S. Colorectal cancer in young adults. Dig Dis Sci. 2015;60:722–733.
3. Kim ER, Kim YH. Clinical application of genetics in management of colorectal cancer. Intest Res. 2014;12:184–193.
4. Song YK, Park YS, Seon CS, et al. Alcohol drinking increased the risk of advanced colorectal adenomas. Intest Res. 2015;13:74–79.
5. Smith RA, Andrews K, Brooks D, et al. Cancer screening in the United States, 2016: A review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin. 2016;66:95–114.
6. Lee BI, Hong SP, Kim SE, et al. Korean guidelines for colorectal cancer screening and polyp detection. Clin Endosc. 2012;45:25–43.
7. Carroll MR, Seaman HE, Halloran SP. Tests and investigations for colorectal cancer screening. Clin Biochem. 2014;47:921–939.
8. Young GP, Symonds EL, Allison JE, et al. Advances in fecal occult blood tests: the FIT revolution. Dig Dis Sci. 2015;60:609–622.
9. Quintero E, Castells A, Bujanda L, et al. Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. N Engl J Med. 2012;366:697–706.
10. Chen LS, Yen AM, Chiu SY, et al. Baseline faecal occult blood concentration as a predictor of incident colorectal neoplasia: longitudinal follow-up of a Taiwanese population-based colorectal cancer screening cohort. Lancet Oncol. 2011;12:551–558.
11. Stegeman I, de Wijkerslooth TR, Mallant-Hent RC, et al. Implementation of population screening for colorectal cancer by repeated fecal immunochemical test (FIT): third round. BMC Gastroenterol. 2012;12:73.
12. Yoo KY. Cancer control activities in the Republic of Korea. Jpn J Clin Oncol. 2008;38:327–333.
13. de Wijkerslooth TR, Stoop EM, Bossuyt PM, et al. Immunochemical fecal occult blood testing is equally sensitive for proximal and distal advanced neoplasia. Am J Gastroenterol. 2012;107:1570–1578.
14. Haug U, Kuntz KM, Knudsen AB, et al. Sensitivity of immunochemical faecal occult blood testing for detecting left- vs right-sided colorectal neoplasia. Br J Cancer. 2011;104:1779–1785.
15. Wong MC, Ching JY, Chan VC, et al. Diagnostic accuracy of a qualitative fecal immunochemical test varies with location of neoplasia but not number of specimens. Clin Gastroenterol Hepatol. 2015;13:1472–1479.
16. Morikawa T, Kato J, Yamaji Y, et al. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. Gastroenterology. 2005;129:422–428.
17. Cubiella J, Castro I, Hernandez V, et al. Characteristics of adenomas detected by fecal immunochemical test in colorectal cancer screening. Cancer Epidemiol Biomarkers Prev. 2014;23:1884–1892.
18. Chiu HM, Lee YC, Tu CH, et al. Association between early stage colon neoplasms and false-negative results from the fecal immunochemical test. Clin Gastroenterol Hepatol. 2013;11:832-838.e831–832-838.e832-838.e832-838.e832.
19. Wu D, Luo HQ, Zhou WX, et al. The performance of three-sample qualitative immunochemical fecal test to detect colorectal adenoma and cancer in gastrointestinal outpatients: an observational study. PLoS ONE. 2014;9:e106648.
20. Rockey DC. Occult gastrointestinal bleeding. N Engl J Med. 1999;341:38–46.
21. Saito H. Screening for colorectal cancer by immunochemical fecal occult blood testing. Jpn J Cancer Res. 1996;87:1011–1024.
22. Fraser CG, Allison JE, Halloran SP, et al. A proposal to standardize reporting units for fecal immunochemical tests for hemoglobin. J Natl Cancer Inst. 2012;104:810–814.
23. Lai EJ, Calderwood AH, Doros G, et al. The Boston bowel preparation scale: a valid and reliable instrument for colonoscopy-oriented research. Gastrointest Endosc. 2009;69:620–625.
24. Lieberman DA, Rex DK, Winawer SJ, et al. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2012;143:844–857.
25. Cha JM, Kozarek RA, La Selva D, et al. Disparities in prevalence, location, and shape characteristics of colorectal neoplasia between South Korean and US patients. Gastrointest Endosc. 2015;82:1080–1086.
26. Soon MS, Kozarek RA, Ayub K, et al. Screening colonoscopy in Chinese and Western patients: a comparative study. Am J Gastroenterol. 2005;100:2749–2755.
27. Lee HS, Jeon SW. Is retroflexion helpful in detecting adenomas in the right colon? A single center interim analysis. Intest Res. 2015;13:326–331.
28. Cha JM, Lee JI, Joo KR, et al. Use of a low cut-off value for the fecal immunochemical test enables better detection of proximal neoplasia. Dig Dis Sci. 2013;58:3256–3262.
29. Lee JK, Liles EG, Bent S, et al. Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis. Ann Intern Med. 2014;160:171.
30. Friis S, Riis AH, Erichsen R, et al. Low-dose aspirin or nonsteroidal anti-inflammatory drug use and colorectal cancer risk: a population-based, case–control study. Ann Intern Med. 2015;163:347–355.
31. Nan H, Hutter CM, Lin Y, et al. Association of aspirin and NSAID use with risk of colorectal cancer according to genetic variants. JAMA. 2015;313:1133–1142.
32. Brenner H, Tao S, Haug U. Low-dose aspirin use and performance of immunochemical fecal occult blood tests. JAMA. 2010;304:2513–2520.
33. Chubak J, Bogart A, Fuller S, et al. Uptake and positive predictive value of fecal occult blood tests: a randomized controlled trial. Prev Med. 2013;57:671–678.
34. Park DI, Ryu S, Kim YH, et al. Comparison of guaiac-based and quantitative immunochemical fecal occult blood testing in a population at average risk undergoing colorectal cancer screening. Am J Gastroenterol. 2010;105:2017–2025.
35. van Roon AH, Wilschut JA, Hol L, et al. Diagnostic yield improves with collection of 2 samples in fecal immunochemical test screening without affecting attendance. Clin Gastroenterol Hepatol. 2011;9:333–339.